8 Reasons a Psychotropic Medication May Be Discontinued

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

This article was originally posted on January 28, 2015 and has since been updated.

Related Videos
Related Content

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: March 20-24

March 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

A Patient’s Heroic Journey Continues

March 22nd 2023

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: March 20-24

March 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

A Patient’s Heroic Journey Continues

March 22nd 2023

Positive Results for Lumateperone in Patients With Mixed Features in Major Depressive Disorder, Bipolar Depression

March 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: March 20-24

March 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

A Patient’s Heroic Journey Continues

March 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.